ANI PHARMACEUTICALS INC (ANIP:NASDAQ)
$76.48 -1.81 (-2.3119%)
Analysed ANI PHARMACEUTICALS INC (ANIP:NASDAQ) News Sources
CGON Stock Up 60.8% in Six Months: Here's What You Need to Know
15-04-2026
yahoo.com
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
14-04-2026
yahoo.com
RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
14-04-2026
yahoo.com
1 Cash-Producing Stock with Promising Prospects and 2 Facing Challenges
14-04-2026
yahoo.com
1 Small-Cap Stock for Long-Term Investors and 2 We Turn Down
13-04-2026
yahoo.com
ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules
13-04-2026
yahoo.com
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
10-04-2026
yahoo.com
Does ANI Pharmaceuticals' (ANIP) New Cardiovascular Generic Deepen Its Niche Strategy Or Stretch It?
10-04-2026
yahoo.com
Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties
09-04-2026
yahoo.com
Is American Well (AMWL) Outperforming Other Medical Stocks This Year?
08-04-2026
yahoo.com
What is the current price of ANI PHARMACEUTICALS INC (ANIP:NASDAQ)?
The current price of ANI PHARMACEUTICALS INC (ANIP:NASDAQ) is $76.48.
ANI PHARMACEUTICALS INC (ANIP:NASDAQ) absolute price change since previous trading day?
The absolute price change of ANI PHARMACEUTICALS INC (ANIP:NASDAQ) since the previous trading day is $-1.81.
ANI PHARMACEUTICALS INC (ANIP:NASDAQ) percentage price change since previous trading day?
The percentage price change of ANI PHARMACEUTICALS INC (ANIP:NASDAQ) since the previous trading day is -2.3119%.
What is the most recent average sentiment score for ANI PHARMACEUTICALS INC (ANIP:NASDAQ)?
The most recent average sentiment score for ANI PHARMACEUTICALS INC (ANIP:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for ANI PHARMACEUTICALS INC (ANIP:NASDAQ)?
The most recent sentiment for ANI PHARMACEUTICALS INC (ANIP:NASDAQ) is .
SEC-8K** Filing Available For ANI PHARMACEUTICALS INC (ANIP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.